Toripalimab, CAS 1924598-82-2

Product Description: Toripalimab is the first domestic anti-tumor PD-1 antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Lin Zhang, et al. Toripalimab: the First Domestic Anti-Tumor PD-1 Antibody in China. Front Immunol. 2022 Jan 12;12:730666.

CAS Number: 1924598-82-2

Molecular Weight: N/A

Compound Purity: 99.30

Research Area: Cancer

Solubility: H2O

Target: PD-1/PD-L1

• SKU: MEXHY-P9978-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9978-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated